Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析

◆英語タイトル:Evgen Pharma Plc (EVG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2347028FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based
compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumors; and reduces the vasospasm and incidence of delayed cerebral ischemia which can lead to cognitive impairment in subarachnoid haemorrhage indications. Its clinical pipeline product is based on proprietary Sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. Evgen Pharma carries out preclinical work in multiple sclerosis and has clinical interest in prostate cancer. It has operations in Wilmslow, Liverpool and London, the UK. Evgen Pharma is headquartered in Wilmslow, the UK.

Evgen Pharma Plc Key Recent Developments

Mar 22,2021: Evgen Pharma: Appointment of Chief Business Officer
Dec 10,2020: Evgen Pharma: Half year report 2020
Sep 24,2020: Evgen Pharma announces appointment of chief executive officer
Sep 15,2020: Juvenescence Announces Licensing Agreement with Evgen Pharma PLC
Jun 15,2020: EVGEN PHARMA: Final Results

This comprehensive SWOT profile of Evgen Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Evgen Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Evgen Pharma Plc – Key Information
Evgen Pharma Plc – Overview
Evgen Pharma Plc – Key Employees
Evgen Pharma Plc – Key Employee Biographies
Evgen Pharma Plc – Key Operational Heads
Evgen Pharma Plc – Major Products and Services
Evgen Pharma Plc – History
Evgen Pharma Plc – Company Statement
Evgen Pharma Plc – Locations And Subsidiaries
Evgen Pharma Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Evgen Pharma Plc – Business Description
Evgen Pharma Plc – Corporate Strategy
Evgen Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Evgen Pharma Plc – Strengths
Evgen Pharma Plc – Weaknesses
Evgen Pharma Plc – Opportunities
Evgen Pharma Plc – Threats
Evgen Pharma Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Evgen Pharma Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Evgen Pharma Plc, Key Information
Evgen Pharma Plc, Key Ratios
Evgen Pharma Plc, Share Data
Evgen Pharma Plc, Major Products and Services
Evgen Pharma Plc, History
Evgen Pharma Plc, Key Employees
Evgen Pharma Plc, Key Employee Biographies
Evgen Pharma Plc, Key Operational Heads
Evgen Pharma Plc, Other Locations
Evgen Pharma Plc, Subsidiaries
Evgen Pharma Plc, Key Competitors
Evgen Pharma Plc, SWOT Analysis
Evgen Pharma Plc, Ratios based on current share price
Evgen Pharma Plc, Annual Ratios
Evgen Pharma Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Egalet Corp (EGLT):医療機器:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • H3 Biomedicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Singapore Technologies Aerospace Ltd.:企業の戦略・SWOT・財務情報
    Singapore Technologies Aerospace Ltd. - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Aerospace Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) provides clinical laboratory services. The company provides testing for drugs abuse using hair analysis. It also offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzo …
  • Vectura Group plc:企業の戦略・SWOT・財務分析
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Itamar Medical Ltd (ITMR)-医療機器分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Forum Energy Metals Corp (FDC):企業の財務・戦略的SWOT分析
    Summary Forum Energy Metals Corp (Forum Energy) formerly Forum Uranium Corp, is a mining and mineral resource company. The company acquires, explores, and develops energy metals, such as uranium and copper in Saskatchewan’s Athabasca Basin. Its projects include Janice Lake Sedimentary Copper Project …
  • Derma Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm …
  • W. R. Grace & Co:企業の戦略・SWOT・財務情報
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the o …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • Consolidated Edison Inc (ED):企業の財務・戦略的SWOT分析
    Consolidated Edison Inc (ED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • GVK Power and Infrastructure Ltd (GVKPIL):電力:M&Aディール及び事業提携情報
    Summary GVK Power and Infrastructure Ltd (GVKPIL), formerly Jegurupadu Operation & Maintenance Company Limited, is a diversified infrastructure company that operates across various sectors including energy, transportation, hospitality, resources, airports, and life sciences. It carries out construct …
  • Saft Groupe SA:企業の戦略的SWOT分析
    Saft Groupe SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Singularlogic Information Systems And Software Technology S.A.:企業の戦略的SWOT分析
    Singularlogic Information Systems And Software Technology S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees …
  • Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monova …
  • Catholic University of Leuven:医療機器:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆